Optimized high-throughput screening of non-coding variants identified from genome-wide association studies
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkac1198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Tunc Morova und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Regulatory Sequences, Nucleic Acid. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, TUBITAK, Turkish Science Academy's Young Scientist Award Program.
Abstract (Originalsprache)
The vast majority of disease-associated single nucleotide polymorphisms (SNP) identified from genome-wide association studies (GWAS) are localized in non-coding regions. A significant fraction of these variants impact transcription factors binding to enhancer elements and alter gene expression. To functionally interrogate the activity of such variants we developed snpSTARRseq, a high-throughput experimental method that can interrogate the functional impact of hundreds to thousands of non-coding variants on enhancer activity. snpSTARRseq dramatically improves signal-to-noise by utilizing a novel sequencing and bioinformatic approach that increases both insert size and the number of variants tested per loci. Using this strategy, we interrogated known prostate cancer (PCa) risk-associated loci and demonstrated that 35% of them harbor SNPs that significantly altered enhancer activity. Combining these results with chromosomal looping data we could identify interacting genes and provide a mechanism of action for 20 PCa GWAS risk regions. When benchmarked to orthogonal methods, snpSTARRseq showed a strong correlation with in vivo experimental allelic-imbalance studies whereas there was no correlation with predictive in silico approaches. Overall, snpSTARRseq provides an integrated experimental and computational framework to functionally test non-coding genetic variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Vancouver Prostate Centre, Vancouver, BC V6H 3Z6, Canada.
- Bioinformatics Interdepartmental Program, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Central RNA Lab, Istituto Italiano di Tecnologia, Genova 16163, Italy.
- Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.
- Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Urologic Science, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
ORCID-Profile: Tunc Morova, Yi Ding, Tommer Schwarz, Claudia Giambartolomei, Faraz Hach, Alexander Gusev, Bogdan Pasaniuc, Nathan A Lack
Förderung
- NCI NIH HHS
- TUBITAK
- Turkish Science Academy's Young Scientist Award Program
- Koç University School of Medicine
Zitieren
APA
Morova, T., Ding, Y., Huang, C. F., Sar, F., Schwarz, T., Giambartolomei, C., Baca, S. C., Grishin, D., Hach, F., Gusev, A., Freedman, M. L., Pasaniuc, B., & Lack, N. A. (2023). Optimized high-throughput screening of non-coding variants identified from genome-wide association studies. Nucleic Acids Research. https://doi.org/10.1093/nar/gkac1198
Vancouver
Morova T, Ding Y, Huang CF, Sar F, Schwarz T, Giambartolomei C, et al. Optimized high-throughput screening of non-coding variants identified from genome-wide association studies. Nucleic Acids Research. 2023. doi:10.1093/nar/gkac1198
BibTeX
@article{Morova2023,
author = {Morova, Tunc and Ding, Yi and Huang, Chia-Chi F and Sar, Funda and Schwarz, Tommer and Giambartolomei, Claudia and Baca, Sylvan C and Grishin, Dennis and Hach, Faraz and Gusev, Alexander and Freedman, Matthew L and Pasaniuc, Bogdan and Lack, Nathan A},
title = {Optimized high-throughput screening of non-coding variants identified from genome-wide association studies},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkac1198}
}
EUVIMED